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To the Editor
In the United States, cancer centers commonly advertise clinical services directly to the 
public. Potential benefits of such advertising include informing patients about available 
treatments and reducing the stigma of cancer.1, 2 Potential risks include misleading 
vulnerable patients and creating false hopes, increasing demand for unnecessary tests and 
treatments, adversely affecting existing clinician-patient relationships, and increasing 
healthcare costs.3, 4 Understanding trends in the advertising spending of cancer centers and 
the characteristics of the centers that spend the most can inform the debate about the impact 
of these advertisements. Our hypothesis was that advertising spending has increased and that 
spending is concentrated among for-profit cancer centers.
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Methods
We conducted a descriptive analysis of cancer center advertising expenditures from January, 
2005 to December, 2014. We obtained data from Kantar Media, an agency that tracks the 
content and number of advertisements across major media channels and calculates 
expenditures based on media type and reach. An advertiser was classified as a “cancer 
center” if its name contained the words “cancer,” “oncology,” “radiation,” or another cancer 
therapy, e.g., CyberKnife. Medical centers advertising cancer services were not included 
unless advertisements mentioned a cancer clinic, center, or institute.
We obtained expenditure data across six media outlets: television, magazines, radio, 
newspapers, billboards, and the Internet. Online advertisements were divided into display 
(presented along the bottom or side of websites) and search (listed as search query results). 
Cancer center websites were not included as Internet advertisements. Data on spending for 
Internet search advertisements were not available until 2010.
We adjusted expenditure data to 2014 U.S. dollars using the Consumer Price Index. We 
identified the highest-spending centers in 2014 by summing data from centers with unique 
names, even if centers had numerous locations. We categorized these centers using publicly 
available data: (1) National Cancer Institute (NCI) designation status, (2) Commission on 
Cancer (CoC) accreditation status, (3) tax-exemption status, (4) metropolitan location(s), 
and (5) number of locations. We also compared patterns of spending among NCI-designated 
centers.
Results
From 2005 to 2014, 890 cancer centers in the United States advertised to the public. Total 
advertising spending was $173 million in 2014. In general, inflation-adjusted spending 
increased for all of the types of advertising we considered (Figure). The greatest relative 
growth in spending was for Internet display ads, increasing from less than 1% of spending in 
2005 ($300,000) to 8% in 2014 ($9 million).
In 2014, 20 cancer centers accounted for 86% of total advertising spending (Table). Cancer 
Treatment Centers of America, a for-profit company with a national network of five 
hospitals, had the largest advertising expenditures, accounting for 59% of total spending. 
Cancer Treatment Centers of America spent $101.7 million: $58.7 million for national 
advertising, $24.2 million for local advertising, and $18.7 million for Internet advertising. 
Only two other cancer centers spent more than $9 million: MD Anderson Cancer Center 
spent $13.9 million and Memorial Sloan Kettering Cancer Center spent $9.1 million. Among 
the 20 centers, 5 (25%) were for-profit, 17 (85%) were CoC-accredited, and 9 (45%) were 
NCI-designated. Seven cities had more than one of the centers: Chicago, Houston, New 
York City, Philadelphia, Phoenix, Seattle, and Tampa.
Of 60 NCI-designated cancer centers, 35 (58%) advertised in 2014, with total spending 
ranging from $900 to $13.9 million. Half of the NCI-designated centers that advertised spent 
less than $4,000; one-fourth spent more than $100,000, and five (8%) spent more than $1 
million.
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Discussion
Between 2005 and 2014, cancer centers in the United States substantially increased their 
advertising spending directed at consumers. These findings likely underestimate total 
spending, as available data did not include advertising in cancer-specific magazines, medical 
center advertising for cancer services unless a specific cancer center was mentioned, or 
charitable promotions placed by affiliated organizations. For example, City of Hope, a 
leading cancer center in Duarte, California, was recently highlighted in the New York Times 
for millions of dollars in annual health care advertising.5 According to Kantar Media, that 
advertising was to promote donations to City of Hope and was not placed by the cancer 
center; our search strategy did not capture such promotional spending.
If current trends continue, cancer center advertising may constitute a major source of patient 
information, raising concerns given evidence of imbalanced advertising content.4 Spending 
on advertising is not a measure of quality of care,6 and physicians and cancer organizations 
should help patients make informed cancer treatment decisions. Further work is needed to 
understand the effect of cancer center advertising on the quality and costs of cancer care.
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Figure 1. Trends in cancer center advertising spending by media channel between 2005 and 2014
Data are from Kantar Media (www.kantarmedia.com). All data were adjusted to 2014 U.S. 
dollars using the Consumer Price Index.
* Print media includes magazines and newspapers.
** Kantar Media did not report Internet search advertising data until 2010.
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